SSB
PMN icon

Sandy Spring Bank’s ProMIS Neurosciences PMN Stock Holding History

Sandy Spring Bank’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-132
Closed -$3.13K – 1284
2024
Q4 		$3.13K Hold
132
– – ﹤0.01% 1012
2024
Q3 		$4.13K Hold
132
– – ﹤0.01% 976
2024
Q2 		$4.95K Hold
132
– – ﹤0.01% 990
2024
Q1 		$6.3K Buy
+132
New +$6.53K ﹤0.01% 929

Other funds holding PMN

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

Sandy Spring Bank's PMN Position: Q1 2025 in Review

Sandy Spring Bank sold out of ProMIS Neurosciences (PMN) in Q1 2025, closing a stake of 132 shares — an estimated $3.13K sold.

Sandy Spring Bank first reported a position in PMN in Q1 2024 and held it in 4 quarters. The position peaked at $6.3K in Q1 2024. 15 funds tracked by Wall St. Rank hold PMN as of Q1 2025.

  • Sandy Spring Bank reported no remaining ProMIS Neurosciences position as of Q1 2025 after selling out during the quarter.
  • Sandy Spring Bank sold 132 ProMIS Neurosciences shares in Q1 2025, an estimated $3.13K.
  • Sandy Spring Bank first reported a position in ProMIS Neurosciences in Q1 2024 and held it in 4 quarters.
  • Sandy Spring Bank's ProMIS Neurosciences position peaked at $6.3K in Q1 2024.
  • 15 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.